(Medical Xpress)—A new drug to prevent the early stages of Alzheimer's disease could enter clinical trials in a few years' time according to scientists.
4.7 / 5 (3) |
2
An article in the September issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in chest computed tomography (CT) scans. Chest CT is the third most commonly perfor ...
5 / 5 (1) |
0
While pharmacologic agents have a demonstrated efficacy in children with Attention-deficit/hyperactivity disorder (ADHD), some children have suboptimal response to a single pharmacologic agent. A recent study by Dr. Timothy ...
5 / 5 (1) |
0
(HealthDay)—A phase I trial of dasatinib combined with paclitaxel and carboplatin has determined the optimal dose of dasatinib and suggested some efficacy in women with advanced or recurrent ovarian cancer, ...
5 / 5 (1) |
0
